Archive

Treatment of Idiopathic Choroidal Neovascular Membrane with Ranibizumab - Our Experience Journal > /en/journal/2019/1/3
Objective: To evaluate the anatomical and functional outcome of ranibizumab therapy in patients with idiopathic choroidal neovascularization (CNV).  File and Methodology: The group consists of 6 patients. Patients were older 18 years but they were under 50 years of age. The monitoring period lasted 12 months. We confirmed active idiopathic CNV in subfoveal position with fluorescein angiography (FA...